TO APPROVE THE WITHDRAWAL OF THE ADMISSION TO TRADING ON THE AQSE GROWTH MARKET OF THE ORDINARY SHARE
THAT THE COMPANY BE RE-REGISTERED AS A PRIVATE LIMITED COMPANY WITH THE NAME OF ANANDA PHARMA LIMITED
TO APPROVE SUBJECT TO AND CONDITIONAL UPON THE PASSING OF RESOLUTIONS 1 AND 2 THE NEW ARTICLES OF ASSOCIATION